North America Lipid Poct Market Analysis

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Healthcare North America Lipid Poct Market Market Analysis
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Lipid Poct Market Analysis

  • Healthcare
  • Published Report
  • May 2021
  • North America
  • 350 Pages
  • No of Tables: 92
  • No of Figures: 34
Buy Now Buy Now

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA LIPID POCT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 MULTIVARIATE MODELLING

2.8 DISTRIBUTION CHANNEL LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES

5.1.2 IMPROVING DIAGNOSIS SEEKING RATE

5.1.3 RISING TECHNOLOGICAL ADVANCEMENTS

5.1.4 RISING GERIATRIC POPULATION ACROSS THE GLOBE

5.1.5 RISING PREFERENCE FOR HOMECARE TESTING

5.2 RESTRAINTS

5.2.1 PRODUCT RECALLS

5.2.2 HIGH COSTS OF PRODUCTS

5.2.3 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS

5.3 OPPORTUNITIES

5.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS

5.3.2 RISING HEALTHCARE EXPENDITURE

5.3.3 PANDEMIC OUTBREAK OF COVID-19

5.3.4 GROWING DEMAND FOR BETTER QUALITY HEALTHCARE AND EARLY DIAGNOSIS

5.4 CHALLENGES

5.4.1 LACK OF ALIGNMENT WITH TEST RESULTS OBTAINED FROM LABORATORIES

5.4.2 LACK OF ACCESSIBILITY

6 IMPACT OF COVID-19 ON THE NORTH AMERICA LIPID POCT MARKET

6.1 IMPACT ON PRICE

6.2 IMPACT ON DEMAND

6.3 IMPACT ON SUPPLY CHAIN

6.4 KEY INITIATIVES BY MARKET PLAYERS DURING THE COVID 19

6.5 CONCLUSION:

1 NORTH AMERICA LIPID POCT MARKET, BY TYPE

1.1 OVERVIEW

1.2 INSTRUMENTS

1.2.1 ANALYZERS

1.2.1.1 PORTABLE

1.2.1.2 HANDHELD

1.2.1.3 STANDALONE

1.2.2 METER

1.2.3 BLOOD MONITORING DEVICE

1.2.4 OTHER POC PRODUCTS

1.3 CONSUMABLES AND KITS

1.3.1 CHOLESTEROL TEST KITS

1.3.2 STRIPS

1.3.3 ACCESSORIES

1.3.4 OTHERS

2 NORTH AMERICA LIPID POCT MARKET, BY APPLICATION

2.1 OVERVIEW

2.2 HYPERLIPIDEMIA

2.3 HYPERTRIGLYCERIDEMIA

2.4 HYPERLIPOPROTEINEMIA

2.5 FAMILIAL HYPERCHOLESTEROLEMIA

2.6 TANGIER DISEASE

2.7 OTHERS

3 NORTH AMERICA LIPID POCT MARKET, BY MODE

3.1 OVERVIEW

3.2 PRESCRIPTION-BASED TESTING

3.3 OTC-BASED TESTING

4 NORTH AMERICA LIPID POCT MARKET, BY BRAND

4.1 OVERVIEW

4.2 ROCHE REFLOTRON

4.3 ROCHE COBAS B 101

4.4 ALERE CHOLESTECH LDX

4.5 ALERE AFINION

4.6 PTS CARDIOCHEK

4.7 OTHERS

5 NORTH AMERICA LIPID POCT MARKET, BY PLATFORM

5.1 OVERVIEW

5.2 LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS

5.3 MOLECULAR DIAGNOSTICS

5.4 IMMUNOASSAYS

5.5 DIPSTICKS

5.6 MICROFLUIDICS

6 NORTH AMERICA LIPID POCT MARKET, BY END USER

6.1 OVERVIEW

6.2 HOSPITALS

6.3 PROFESSIONAL DIAGNOSTIC CENTERS

6.3.1 CLINICAL LABORATORIES

6.3.2 OUTPATIENT HEALTHCARE & AMBULATORY CARE SETTINGS

6.4 HOME CARE

6.5 RESEARCH LABORATORIES

6.6 OTHER END USERS

7 NORTH AMERICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL

7.1 OVERVIEW

7.2 DIRECT TENDERS

7.3 RETAIL SALES

8 NORTH AMERICA LIPID POCT MARKET, BY REGION

8.1 NORTH AMERICA

8.1.1 U.S.

8.1.2 CANADA

8.1.3 MEXICO

9 NORTH AMERICA LIPID POCT MARKET: COMPANY LANDSCAPE

9.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

10 SWOT ANALYSIS

11 COMPANY PROFILES

11.1 F. HOFFMANN-LA ROCHE LTD

11.1.1 COMPANY SNAPSHOT

11.1.2 REVENUE ANALYSIS

11.1.3 COMPANY SHARE ANALYSIS

11.1.4 PRODUCT PORTFOLIO

11.1.5 RECENT DEVELOPMENT

11.2 ABBOTT

11.2.1 COMPANY SNAPSHOT

11.2.2 REVENUE ANALYSIS

11.2.3 COMPANY SHARE ANALYSIS

11.2.4 PRODUCT PORTFOLIO

11.2.5 RECENT DEVELOPMENT

11.3 SIEMENS HEALTHCARE GMBH (A SUBSIDIARY OF SIEMENS)

11.3.1 COMPANY SNAPSHOT

11.3.2 REVENUE ANALYSIS

11.3.3 COMPANY SHARE ANALYSIS

11.3.4 PRODUCT PORTFOLIO

11.3.5 RECENT DEVELOPMENTS

11.4 QUEST DIAGNOSTICS INCORPORATED

11.4.1 COMPANY SNAPSHOT

11.4.2 REVENUE ANALYSIS

11.4.3 COMPANY SHARE ANALYSIS

11.4.4 PRODUCT PORTFOLIO

11.4.5 RECENT DEVELOPMENTS

11.5 A. MENARINI DIAGNOSTICS S.R.L

11.5.1 COMPANY SNAPSHOT

11.5.2 COMPANY SHARE ANALYSIS

11.5.3 PRODUCT PORTFOLIO

11.5.4 RECENT DEVELOPMENT

11.6 ACON LABORATORIES, INC.

11.6.1 COMPANY SNAPSHOT

11.6.2 PRODUCT PORTFOLIO

11.6.3 RECENT DEVELOPMENT

11.7 AMD SOLUTIONS

11.7.1 COMPANY SNAPSHOT

11.7.2 PRODUCT PORTFOLIO

11.7.3 RECENT DEVELOPMENTS

11.8 CALLEGARI SRL

11.8.1 COMPANY SNAPSHOT

11.8.2 PRODUCT PORTFOLIO

11.8.3 RECENT DEVELOPMENTS

11.9 EUROMEDIX

11.9.1 COMPANY SNAPSHOT

11.9.2 PRODUCT PORTFOLIO

11.9.3 RECENT DEVELOPMENT

11.1 GENERAL LIFE BIOTECHNOLOGY CO., LTD.

11.10.1 COMPANY SNAPSHOT

11.10.2 PRODUCT PORTFOLIO

11.10.3 RECENT DEVELOPMENTS

11.11 JANT PHARMACAL CORPORATION

11.11.1 COMPANY SNAPSHOT

11.11.2 PRODUCT PORTFOLIO

11.11.3 RECENT DEVELOPMENT

11.12 MICO BIOMED

11.12.1 COMPANY SNAPSHOT

11.12.2 PRODUCT PORTFOLIO

11.12.3 RECENT DEVELOPMENTS

11.13 NOVA BIOMEDICAL

11.13.1 COMPANY SNAPSHOT

11.13.2 PRODUCT PORTFOLIO

11.13.3 RECENT DEVELOPMENTS

11.14 PRIMA LAB SA

11.14.1 COMPANY SNAPSHOT

11.14.2 PRODUCT PORTFOLIO

11.14.3 RECENT DEVELOPMENTS

11.15 PTS DIAGNOSTICS

11.15.1 COMPANY SNAPSHOT

11.15.2 PRODUCT PORTFOLIO

11.15.3 RECENT DEVELOPMENTS

11.16 SD BIOSENSOR, INC.

11.16.1 COMPANY SNAPSHOT

11.16.2 PRODUCT PORTFOLIO

11.16.3 RECENT DEVELOPMENTS

11.17 SKYLA CORPORATION

11.17.1 COMPANY SNAPSHOT

11.17.2 PRODUCT PORTFOLIO

11.17.3 RECENT DEVELOPMENTS

11.18 TASCOM

11.18.1 COMPANY SNAPSHOT

11.18.2 PRODUCT PORTFOLIO

11.18.3 RECENT DEVELOPMENT

11.19 TRINITY BIOTECH

11.19.1 COMPANY SNAPSHOT

11.19.2 REVENUE ANALYSIS

11.19.3 PRODUCT PORTFOLIO

11.19.4 RECENT DEVELOPMENTS

11.2 SAMSUNG MEDISON CO., LTD.

11.20.1 COMPANY SNAPSHOT

11.20.2 PRODUCT PORTFOLIO

11.20.3 RECENT DEVELOPMENT

12 QUESTIONNAIRE

13 RELATED REPORTS

List of Table

LIST OF TABLES

TABLE 1 BELOW MENTIONED TABLE SHOWS THE COST OF VARIOUS LIPID POCT DEVICES OFFERED BY DIFFERENT MANUFACTURERS:

TABLE 1 NORTH AMERICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 2 NORTH AMERICA INSTRUMENTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 NORTH AMERICA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 4 NORTH AMERICA ANALYZERS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA CONSUMABLES & KITS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE , 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA HYPERLIPIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA HYPERTRIGLYCERIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA HYPERLIPOPROTEINEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 NORTH AMERICA TANGIER DISEASE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA LIPID POCT MARKET, BY MODE, 2019 – 2028, (USD MILLION)

TABLE 15 NORTH AMERICA PRESCRIPTION-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA OTC-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 NORTH AMERICA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA ROCHE REFLOTRON IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA ROCHE COBAS B 101 IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA ALERE CHOLESTECH LDX IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA ALERE AFINION IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA PTS CARDIOCHEK IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 NORTH AMERICA OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA MOLECULAR DIAGNOSTICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA IMMUNOASSAYS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 NORTH AMERICA DIPSTICKS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA MICROFLUIDICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA HOSPITALS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 NORTH AMERICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 34 NORTH AMERICA HOME CARE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA RESEARCH LABORATORIES IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA OTHER END USERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA DIRECT TENDERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA RETAIL SALES IN LIPID POCT MARKET, BY REGION 2019-2028 (USD MILLION)

TABLE 40 NORTH AMERICA LIPID POCT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 41 NORTH AMERICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 42 NORTH AMERICA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 43 NORTH AMERICA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 44 NORTH AMERICA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 45 NORTH AMERICA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 46 NORTH AMERICA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 47 NORTH AMERICA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 48 NORTH AMERICA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 49 NORTH AMERICA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 50 NORTH AMERICA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 51 NORTH AMERICA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 NORTH AMERICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 53 NORTH AMERICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 54 U.S. LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 55 U.S. INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 56 U.S. ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 57 U.S. ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 58 U.S. CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 59 U.S. LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 60 U.S. LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 61 U.S. LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 62 U.S. LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 63 U.S. LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 64 U.S. LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 65 U.S. PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 66 U.S. LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 67 CANADA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 CANADA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 69 CANADA ANALYZERS IN POINT OF CARE TESTING MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 70 CANADA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 71 CANADA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 72 CANADA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 73 CANADA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 74 CANADA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 75 CANADA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 76 CANADA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 77 CANADA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 78 CANADA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 79 CANADA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 80 MEXICO LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 81 MEXICO INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 82 MEXICO ANALYZERS IN POINT OF CARE TESTING MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 83 MEXICO ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 84 MEXICO CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 85 MEXICO LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 86 MEXICO LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 87 MEXICO LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)

TABLE 88 MEXICO LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)

TABLE 89 MEXICO LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 90 MEXICO LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 91 MEXICO PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 92 MEXICO LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

 

List of Figure

LIST OF FIGURES

FIGURE 1 NORTH AMERICA LIPID POCT MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA LIPID POCT MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA LIPID POCT MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA LIPID POCT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA LIPID POCT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA LIPID POCT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA LIPID POCT MARKET: MULTIVARIATE MODELLING

FIGURE 8 NORTH AMERICA LIPID POCT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA LIPID POCT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA LIPID POCT MARKET: SEGMENTATION

FIGURE 11 INCREASING PREVALENCE OF CHRONIC DISEASE AND IMPROVING DIAGNOSIS SEEKING RATE ARE EXPECTED TO DRIVE THE NORTH AMERICA LIPID POCT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA LIPID POCT MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA LIPID POCT MARKET

FIGURE 14 TOP 10 CAUSES OF DEATHS DUE TO CHRONIC INFECTIONS IN EGYPT

FIGURE 15 MEDICAL DEVICE SPENDING VS. NATIONAL HEALTH EXPENDITURES IN 2016

FIGURE 1 NORTH AMERICA LIPID POCT MARKET: BY TYPE, 2020

FIGURE 2 NORTH AMERICA LIPID POCT MARKET: BY TYPE, 2019-2028 (USD MILLION)

FIGURE 3 NORTH AMERICA LIPID POCT MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 4 NORTH AMERICA LIPID POCT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 5 NORTH AMERICA LIPID POCT MARKET: BY APPLICATION, 2020

FIGURE 6 NORTH AMERICA LIPID POCT MARKET: BY APPLICATION, 2019-2028 (USD MILLION)

FIGURE 7 NORTH AMERICA LIPID POCT MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 8 NORTH AMERICA LIPID POCT MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 9 NORTH AMERICA LIPID POCT MARKET: BY MODE, 2020

FIGURE 10 NORTH AMERICA LIPID POCT MARKET: BY MODE, 2019-2028 (USD MILLION)

FIGURE 11 NORTH AMERICA LIPID POCT MARKET: BY MODE, CAGR (2021-2028)

FIGURE 12 NORTH AMERICA LIPID POCT MARKET: BY MODE, LIFELINE CURVE

FIGURE 13 NORTH AMERICA LIPID POCT MARKET: BY BRAND, 2020

FIGURE 14 NORTH AMERICA LIPID POCT MARKET: BY BRAND, 2020-2028 (USD MILLION)

FIGURE 15 NORTH AMERICA LIPID POCT MARKET: BY BRAND, CAGR (2021-2028)

FIGURE 16 NORTH AMERICA LIPID POCT MARKET: BY BRAND, LIFELINE CURVE

FIGURE 17 NORTH AMERICA LIPID POCT MARKET: BY PLATFORM, 2020

FIGURE 18 NORTH AMERICA LIPID POCT MARKET: BY PLATFORM, 2019-2028 (USD MILLION)

FIGURE 19 NORTH AMERICA LIPID POCT MARKET: BY PLATFORM, CAGR (2021-2028)

FIGURE 20 NORTH AMERICA LIPID POCT MARKET: BY PLATFORM, LIFELINE CURVE

FIGURE 21 NORTH AMERICA LIPID POCT MARKET: BY END USER, 2020

FIGURE 22 NORTH AMERICA LIPID POCT MARKET: BY END USER, 2019-2028 (USD MILLION)

FIGURE 23 NORTH AMERICA LIPID POCT MARKET: BY END USER, CAGR (2021-2028)

FIGURE 24 NORTH AMERICA LIPID POCT MARKET: BY END USER, LIFELINE CURVE

FIGURE 25 NORTH AMERICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 26 NORTH AMERICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

FIGURE 27 NORTH AMERICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 28 NORTH AMERICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 29 NORTH AMERICA LIPID POCT MARKET: SNAPSHOT (2020)

FIGURE 30 NORTH AMERICA LIPID POCT MARKET: BY COUNTRY (2020)

FIGURE 31 NORTH AMERICA LIPID POCT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 32 NORTH AMERICA LIPID POCT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 33 NORTH AMERICA LIPID POCT MARKET: BY TYPE (2021-2028)

FIGURE 34 NORTH AMERICA LIPID POCT MARKET: COMPANY SHARE 2020 (%)

 

Browse Related Pages

Banner